Discontinuation report HIBERIX
| Report ID | 175258 |
| Drug Identification Number | 02239200 |
| Brand name | HIBERIX |
| Common or Proper name | Haemophilus influenzae type b (Hib) conjugate vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE |
| Strength(s) | 10MCG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | J07AG |
| ATC description | BACTERIAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-03-24 |
| Remaining supply date | 2023-06-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-03-29 | French | Compare |
| v3 | 2023-03-29 | English | Compare |
| v2 | 2022-11-18 | French | Compare |
| v1 | 2022-11-18 | English | Compare |
Showing 1 to 4 of 4